MARKET

AMRX

AMRX

Amneal Pharmaceuticals Inc
NASDAQ
13.20
-0.52
-3.79%
After Hours: 13.36 +0.16 +1.21% 19:49 05/08 EDT
OPEN
13.62
PREV CLOSE
13.72
HIGH
13.81
LOW
13.12
VOLUME
1.52M
TURNOVER
--
52 WEEK HIGH
15.42
52 WEEK LOW
7.02
MARKET CAP
4.21B
P/E (TTM)
59.51
1D
5D
1M
3M
1Y
5Y
1D
Amneal Pharmaceuticals (AMRX) Profit Rebound Challenges Concerns Over Earnings Quality
Simply Wall St · 2d ago
Amneal (AMRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Revised)
NASDAQ · 2d ago
Amneal Pharmaceuticals beats top-line and bottom-line estimates; reaffirms FY26 outlook
Seeking Alpha · 3d ago
Amneal Shareholders Back Board, Pay and Auditor at Meeting
TipRanks · 3d ago
Amneal Q1 net income more than doubles to $78 million; net revenue rises 3.9% to $722.52 million
PUBT · 3d ago
Amneal Pharmaceuticals backs FY26 adjusted EPS view 95c-$1.05, consensus $1.00
TipRanks · 3d ago
Amneal Pharmaceuticals held annual shareholder meeting, director nominees elected
PUBT · 3d ago
*Amneal Pharmaceuticals 1Q Adj EPS 27c >AMRX
Dow Jones · 3d ago
More
About AMRX
Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.

Webull offers Amneal Pharmaceuticals Inc stock information, including NASDAQ: AMRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AMRX stock methods without spending real money on the virtual paper trading platform.